Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Candesartan Cilexitil 1 mg/mL Syrup

Author(s):  Allen Loyd V Jr

Issue:  May/Jun 2022 - Volume 26, Number 3
View All Articles in Issue

Page(s):  234

Note:  Electronic version includes supplemental material.

Candesartan Cilexitil 1 mg/mL Syrup Page 1

Download in electronic PDF format for $75

Abstract:  A formulation for preparing Candesartan Cilexitil 1 mg/mL Syrup. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, candesartan cilexitil, antihypertensive agent, hypertension, high blood pressure, angiotensin II receptor antagonist

Related Categories: FORMULATIONS, CARDIOLOGY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Candesartan Cilexitil 1 mg/mL Syrup
Allen Loyd V Jr
May/Jun 2022
Pg. 234

Candesartan Cilexetil 0.1-mg/mL to 2.0-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2017
Pg. 232

Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP
Allen Loyd V Jr
Jul/Aug 2019
Pg. 315

Candesartan Cilexetil 8 mg Liquid-Filled Capsules
Allen Loyd V Jr
Mar/Apr 2017
Pg. 147

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Basics of Compounding for Cough
Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465

Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312

Losartan Potassium 2.5-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2007
Pg. 248

Valsartan 4 mg/mL in Syrup NF
Allen Loyd V Jr
Mar/Apr 2020
Pg. 139

Valsartan 4 mg/mL in Vehicle for Oral Solution USP
Allen Loyd V Jr
Sep/Oct 2019
Pg. 412

Losartan Potassium 2.5-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2023
Pg. 326

Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs
Harrington Catherine A
, Cauffield Jacintha
May/Jun 2005
Pg. 201-205

Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure
Harrington Catherine A
, Cauffield Jacintha
Mar/Apr 2005
Pg. 117-119

Verapamil Hydrochloride 50 mg/mL in Ora-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
Sep/Oct 2019
Pg. 413

Valsartan 16-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2019
Pg. 237

Propranolol Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2014
Pg. 330

Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Mixon William
, Helms Scott R
Sep/Oct 2008
Pg. 392-397

Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System
Taghi Hassanien Sagban
, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
Jul/Aug 2023
Pg. 340-346

Basics of Compounding for Iontophoresis, Part II
Allen Loyd V Jr
Jul/Aug 2002
Pg. 288-292

Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2018
Pg. 233

Return to Top